newsfilter
← Latest News
Earnings Call Transcripts·

THE GRAFT-VERSUS-HOST DISEASE EXHANGE: EXPERT PERSPECTIVES ON EVOLVING CLINICAL PROACTIVE WITH DR. SUSAN PROCKOP - TIGENIX NV

Thank you all for joining. These are my disclosures. Not listed here is probably my biggest disclosure, which is my father was a basic scientist engaged in mesenchymal stromal cell research. And so I know more about MSCs

Company
TIGENIX NV
Keywords
TIGENIX NV